WuXi Biologics (Cayman) Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 2269.HK | 3759.HK | BIOCON.NS | 095700.KQ | 1548.HK | 085660.KQ | |
|---|---|---|---|---|---|---|
| Market cap | 200.38B | 55.85B | 592.87B | 94.14B | 76.81B | 677.77B |
| P/E (TTM) | 36.6 | 27.4 | 121.5 | — | — | — |
| Forward P/E | 22.3 | 17.2 | 33.3 | — | 85.8 | — |
| Price/book | 3.5 | 2.8 | 1.7 | — | 2.4 | — |
| Dividend yield | — | 0.78% | 0.15% | — | — | — |
| 1-year change | +38.22% | +19.72% | −10.58% | −60.56% | +109.10% | −45.74% |
| Today | +0.75% | +3.47% | +5.10% | +0.73% | −0.94% | +5.96% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 2269.HK news ›WuXi Biologics (Cayman) Inc.: Relative Strength Chart - Stock Hong Kong S.E.
Compare WuXi Biologics (Cayman) Inc. with the company of your choice via a Relative Strength chart. Real-time 2269 price, Hong Kong S.E. stock exchange Relative Strength Chart WuXi Biologics (Cayman) Inc. Biotechnology & Medical Research…
Jefferies Adjusts WuXi Biologics (Cayman)'s Price Target to HK$60 From HK$50, Keeps at Buy
WuXi Biologics has an average rating of overweight and mean price target of HK$50.15, according to analysts polled by FactSet. ... WuXi Biologics (Cayman) Inc. Biotechnology & Medical Research Jefferies Adjusts WuXi Biologics (Cayman)'s…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.